Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; and products for surgical treatment of tumors or vascular diseases, such as aneurysms. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Industry, Sector and Symbol
Stock Exchange ETR
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolETR:AFX
Previous Symbol
CUSIPN/A
Phone+49-3641-2200
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees3,000
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions
What is Carl Zeiss Meditec's stock symbol?
Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."
What price target have analysts set for AFX?
9 brokerages have issued twelve-month target prices for Carl Zeiss Meditec's shares. Their predictions range from €51.00 to €75.00. On average, they anticipate Carl Zeiss Meditec's share price to reach €65.00 in the next year. This suggests that the stock has a possible downside of 4.1%. View Analyst Price Targets for Carl Zeiss Meditec.
What is the consensus analysts' recommendation for Carl Zeiss Meditec?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 3 sell ratings and 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec.
Has Carl Zeiss Meditec been receiving favorable news coverage?
News articles about AFX stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Carl Zeiss Meditec earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the immediate future.
Who are some of Carl Zeiss Meditec's key competitors?
Some companies that are related to Carl Zeiss Meditec include 3D Signatures (DXD), BioNano Genomics (BNGOU), Cambridge Cognition (COG), Carl Data Solutions (CRL), Co-Diagnostics (CODX), Deepmatter Group (DMTR), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Genedrive (GDR), GeneNews (GEN), Imaging Dynamics (IDL), LED Medical Diagnostics (LMD), Lexagene (LXG), MaxCyte (MXCT) and Med Biogene (MBI).
Who are Carl Zeiss Meditec's key executives?
Carl Zeiss Meditec's management team includes the folowing people:
- Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 55)
- Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 53)
- Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management Board
- Mr. Sebastian Frericks, Director of Investor Relations
- Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit
What is Carl Zeiss Meditec's stock price today?
One share of AFX stock can currently be purchased for approximately €67.80.
What is Carl Zeiss Meditec's official website?
How can I contact Carl Zeiss Meditec?
Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.
MarketBeat Community Rating for Carl Zeiss Meditec (ETR AFX)
MarketBeat's community ratings are surveys of what our community members think about Carl Zeiss Meditec and other stocks. Vote "Outperform" if you believe AFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
